Specimens for hormone receptor analysis were collected at the time of surgery from the tumor mass. Samples were frozen in liquid nitrogen and stored at -80°C until use. From the samples to be assayed for receptor analysis, frozen sections for histological assessment were routinely taken to ensure that there was only a minimum of connective tissue and no normal mucosa in these. Furthermore, some of these sections were used for the immunohistochemical demonstration of nuclear oestrogen receptors with the ERICA kit (Estrogen Receptor Immunochemical Assay, Abbot Laboratories, North Chicago, Illinois).
Type II oestrogen binding sites in human colorectal carcinoma Type II oestrogen binding sites have been found in both normal and neoplastic rat and human "classic" target tissues,"1 21 human peripheral blood mononuclear cells,'9 acute lymphoid and myeloid leukaemias,22 and rat23 and human pancreas,'7 but their role is still unknown. In this respect it has been shown that there is a close relation between increased numbers of these sites and true uterine growth.415 Moreover, in peripheral blood mononuclear cells type II oestrogen binding sites are modulated by oestrogen.'9 There is also a positive correlation between the numbers of type II oestrogen binding sites and concentrations of progesterone receptors. ' From these data it seems likely that type II oestrogen binding sites constitute an important aspect of oestrogen sensitivity. On the other hand, it may be argued that these sites in normal and neoplastic tissues have no physiological importance because of their apparent low affinity for oestrogens and the low circulating oestrogen concentrations. It is possible, however, that higher concentrations of hormone exist within tissues or subcellular compartments. Binding sites need not be saturated to be functional: oestrogen bound to a small number of sites (spare receptors) can be effective in hormone action.
Our results indicate that in colorectal cancer the absence of oestrogen receptors does not necessarily preclude the presence of high affinity progesterone receptors. This finding agrees with the observation that oestrogen treatment is not needed to stimulate the production of progesterone receptors in chicken intestinal mesothelium and smooth muscle."4
In conclusion, the presence of type II oestrogen binding sites rather than that of oestrogen receptors could provide support for earlier suggestions2 3 25 that there is a female sex hormone component in the risk profile for colorectal cancer.
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